Future Healthcare Today
  • About
  • Payer
  • Provider
  • Pharma & Life Sciences
Subscribe
No Result
View All Result
  • Digital Transformation
  • Telehealth
  • Cybersecurity
  • Patient Experience
  • Clinicians
  • Resources
    • COVID-19
Future Healthcare Today
  • Digital Transformation
  • Telehealth
  • Cybersecurity
  • Patient Experience
  • Clinicians
  • Resources
    • COVID-19
No Result
View All Result
Future Healthcare Today
No Result
View All Result
Home Clinicians

NASH Management Is Easier for Clinicians with the Right Educational Resources

by Heidi Bullman
June 30, 2020
in Clinicians, Uncategorized
Reading Time: 3 mins read
A A
NASH Management Is Easier for Clinicians with the Right Educational Resources
Share on FacebookShare on Twitter

Research indicates that nonalcoholic steatohepatitis (NASH) will be the leading cause of liver transplants for the general population in the U.S. this year. Driven by inflammation and resulting in fibrosis, NASH is usually a silent disease, which goes unnoticed for years until the liver becomes severely damaged. Currently recognized as the leading cause of liver transplants for females, there are several clinical trials and exploratory treatments in process. To better understand the disease and the resources available to clinicians to help manage patients with NASH, we sat down with Zachary Schwartz, MSc, Scientific Director at Clinical Care Options.

Future Healthcare Today (FHT): Thanks for talking with us, Zachary. First and foremost, what is NASH?

Zachary Schwartz (ZS): Thanks for having me. NASH, or nonalcoholic steatohepatitis, is a fatty liver disease that is unrelated to alcohol consumption. The fat causes inflammation and damage in the liver.

FHT: How much of the population is affected by NASH and how does it impact quality of life?

ZS: The number of people affected by the disease is growing at an alarming rate. It’s growing in tandem with diabetes and obesity since these comorbidities increase a person’s risk for developing NASH. People usually don’t show symptoms in the initial stages–it’s usually found by accident. If the NASH progresses– which can take years– that’s when serious problems occur including fibrosis, cirrhosis, end stage liver disease, and liver cancer. It can ultimately result in the need for a liver transplant.

FHT: How do clinicians help patients manage and treat symptoms?

ZS: That’s the biggest problem clinicians face because, right now, there’s no FDA-approved treatment. The guidelines recommend weight loss, which can help to reduce long-term damage to the liver. They also recommend considering pioglitazone, which is an anti-diabetic medication, or vitamin E. Both of these are off label. However, this lack of treatments may change soon as data emerges on new compounds in clinical studies.

FHT: How is a resource like Clinical Care Options helpful for clinicians/advanced practicing clinicians in managing patients with NASH?

ZS:
We have a wealth of resources for clinicians and APCs including recorded webinars and downloadable slides on both the basics of NASH and also the latest hot topics from conferences and experts. Most of our information focuses on two aspects of NASH: diagnosis and emerging treatment options. We’re here to help clinicians understand new and relevant research, who’s at risk, who should be screened and how to do it, and even how tests are changing based on emerging data. Above all, our main priority is to help clinicians and practitioners better educate and guide patients as they navigate the challenges associated with a disease like NASH.

Discover NASH Resources.

Tags: APCsClinical Care Optionscliniciansfibrosisliver diseaseNASHnonalcoholic steatohepatitis

RELATED POSTS

Atrium Health Uses Wearable Devices to Benefit Patients and Generate Valuable Public Health Insight
Clinicians

Atrium Health Uses Wearable Devices to Benefit Patients and Generate Valuable Public Health Insight

September 28, 2020
To Deliver Value to Clinicians COVID-19 Education Must be Continually Updated
Clinicians

To Deliver Value to Clinicians COVID-19 Education Must be Continually Updated

September 2, 2020
Medication History
Clinicians

The Healthiverse and Hospitals—Battling Medication History Misinformation

August 26, 2020

TRENDING NOW

  • Digital Progress

    Unlocking Digital Progress in Healthcare

    520 shares
    Share 208 Tweet 130
  • Three Digital Health Trends to Watch at CES 2024

    499 shares
    Share 200 Tweet 125
  • Targeted Interventions to Reduce Unnecessary ER Utilization, Lower Costs, and Improve Outcomes

    502 shares
    Share 201 Tweet 126
  • The Future of Medical Research Explored by Industry Experts 


    537 shares
    Share 215 Tweet 134
  • Defense in Depth Strategy Protects Healthcare Organizations from Cyber Attacks

    672 shares
    Share 269 Tweet 168

CONNECT WITH US

BECOME AN INSIDER

Get Future Healthcare Today Insider news and updates in your inbox.

Strategic Communications Group is a digital media company that helps business-to-business marketers drive customer demand through content marketing, content syndication, and lead identification.

Related Communities

Financial Technology Today
Government Technology Insider
Modern Marketing Today
Retail Technology Insider
Today’s Modern Educator

Quick Links

  • Home – 2021
  • About
  • Contact Us

Become a Sponsor

Future Healthcare Today offers content and advertising sponsorships to leading healthcare solution and service providers. Interested in becoming a sponsor? Contact us!

© 2023 Strategic Communications Group, Inc.
Privacy Policy      |      Terms of Service

No Result
View All Result
  • Home
  • About
  • Payer
  • Provider
  • Pharma & Life Sciences
  • Categories
    • Digital Transformation
    • Telehealth
    • Cybersecurity
    • Patient Experience
    • Clinicians
  • Contact Us